Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Drug:
Beta-1 Selective:
ISA:
Approximate Dose Equivalence:
Major Elimination Route:
Reference
Important note: Unable to
find additional sources to validate equivalent dosages listed.
Shalansky K, Sunderji R, et al. CSU
Pharmaceutical Sciences. Drug and Therapeutics Newsletter 2004;11(3);5.
The authors make no claims of the accuracy of the
information contained herein; and these suggested doses are not a
substitute for clinical judgement. Neither GlobalRPh Inc. nor any other
party involved in the preparation of this program shall be liable for
any special, consequential, or exemplary damages resulting in whole or
part from any user's use of or reliance upon this material.PLEASE READ
THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY
ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND
CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer